• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别和血清雌二醇水平对高密度脂蛋白介导的胆固醇逆转运的影响。

The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.

机构信息

Turku PET Centre, Turku University Central Hospital, Turku, Finland.

出版信息

Eur J Clin Invest. 2013 Apr;43(4):317-23. doi: 10.1111/eci.12044. Epub 2013 Feb 9.

DOI:10.1111/eci.12044
PMID:23397902
Abstract

OBJECTIVE

Premenopausal women have a lower incidence of cardiovascular disease compared to men of the same age. Endogenous oestrogens, especially estradiol, presumably protect against atherosclerosis by a variety of mechanisms. Reverse cholesterol transport (RCT) mechanisms also provide protection against this disease. RCT is defined as the removal of cholesterol from peripheral macrophage foam cells, via high-density lipoproteins (HDL), and cholesterol transportation to the liver for excretion. We have previously shown in a preliminary study that HDL, isolated from premenopausal women, enhanced macrophage cholesterol efflux compared to HDL derived from age-matched male subjects.

MATERIALS AND METHODS

Here, we expanded this study by analysing a larger population of healthy volunteers and evaluated the capacity of HDL derived from women with high or low serum E2 concentrations, mainly representing premenopausal and postmenopausal women, respectively, or men (each group consisting of 30 subjects) to facilitate cholesterol removal from human THP-1 macrophages. HDL isolated from serum samples was incubated with [(3)H] cholesterol oleate-loaded macrophages for 16 h, after which cholesterol efflux to HDL was determined.

RESULTS

No significant differences in the efflux-promoting ability of HDL existed among the three groups. Relevant plasma factors involved in further steps of RCT, such as cholesterol ester transfer protein (CETP), phospholipid transfer protein (PLTP) and lecithin:cholesterol acyltransferase (LCAT) activities were also analysed, but no differences were observed among the study groups.

CONCLUSION

The results do not support a role for estradiol status or gender in modifying the initial step of RCT as a protective mechanism against cardiovascular disease.

摘要

目的

与同年龄的男性相比,绝经前女性患心血管疾病的发病率较低。内源性雌激素,尤其是雌二醇,可能通过多种机制预防动脉粥样硬化。胆固醇逆转运(RCT)机制也为预防这种疾病提供了保护。RCT 的定义是通过高密度脂蛋白(HDL)从外周巨噬细胞泡沫细胞中去除胆固醇,并将胆固醇转运到肝脏进行排泄。我们之前的初步研究表明,与来自年龄匹配的男性受试者的 HDL 相比,从绝经前女性中分离出的 HDL 增强了巨噬细胞胆固醇流出。

材料和方法

在这里,我们通过分析更大的健康志愿者群体扩展了这项研究,并评估了 HDL 的能力,这些 HDL 来自血清 E2 浓度高或低的女性,主要代表绝经前和绝经后女性,或男性(每组 30 名受试者),以促进人 THP-1 巨噬细胞中胆固醇的去除。将从血清样本中分离出的 HDL 与 [(3)H] 胆固醇油酸负载的巨噬细胞孵育 16 小时后,测定胆固醇向 HDL 的流出。

结果

三组之间 HDL 促进流出的能力没有显著差异。还分析了涉及 RCT 进一步步骤的相关血浆因子,如胆固醇酯转移蛋白(CETP)、磷脂转移蛋白(PLTP)和卵磷脂:胆固醇酰基转移酶(LCAT)活性,但研究组之间没有观察到差异。

结论

这些结果不支持雌二醇状态或性别在修饰 RCT 的初始步骤中发挥作用,作为预防心血管疾病的保护机制。

相似文献

1
The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.性别和血清雌二醇水平对高密度脂蛋白介导的胆固醇逆转运的影响。
Eur J Clin Invest. 2013 Apr;43(4):317-23. doi: 10.1111/eci.12044. Epub 2013 Feb 9.
2
Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters.高密度脂蛋白相关的17β-雌二醇脂肪酰酯可增强人类巨噬细胞的胆固醇流出潜力。
J Steroid Biochem Mol Biol. 2009 Aug;116(1-2):44-9. doi: 10.1016/j.jsbmb.2009.04.008. Epub 2009 May 3.
3
HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.重度饮酒者的高密度脂蛋白2(HDL2)通过富含磷脂的HDL 2b颗粒增强了来自未加工巨噬细胞的胆固醇流出。
Alcohol Clin Exp Res. 2008 Jun;32(6):991-1000. doi: 10.1111/j.1530-0277.2008.00660.x.
4
CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection.小鼠中胆固醇酯转运蛋白(CETP)活性的变化不会影响高密度脂蛋白(HDL)的两个主要抗动脉粥样硬化特性:巨噬细胞特异性逆向胆固醇转运和低密度脂蛋白(LDL)抗氧化保护。
Atherosclerosis. 2008 Feb;196(2):505-13. doi: 10.1016/j.atherosclerosis.2007.05.007. Epub 2007 Jun 22.
5
Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy.同型半胱氨酸水平低和高的人群中,巨噬细胞胆固醇向血浆和高密度脂蛋白的流出:FIELD 子研究。
Atherosclerosis. 2011 Nov;219(1):259-65. doi: 10.1016/j.atherosclerosis.2011.05.018. Epub 2011 May 25.
6
Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.逆向胆固醇转运的分子机制:前β迁移高密度脂蛋白与血浆卵磷脂/胆固醇酰基转移酶的反应
Biochemistry. 2004 Nov 23;43(46):14811-20. doi: 10.1021/bi0485629.
7
Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.活性磷脂转运蛋白通过生成两种类型的受体颗粒增强巨噬细胞泡沫细胞中的胆固醇流出。
Biochemistry. 2007 Oct 23;46(42):11979-86. doi: 10.1021/bi700833h. Epub 2007 Sep 27.
8
A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.低饱和脂肪、低胆固醇饮食可降低血浆胆固醇酯转运蛋白(CETP)活性和前β-高密度脂蛋白(pre beta-HDL)的形成,但不影响1型糖尿病患者细胞内胆固醇向血浆的流出。
Scand J Clin Lab Invest. 2005;65(8):729-37. doi: 10.1080/00365510500375289.
9
Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.托彻普(torcetrapib)对胆固醇酯转运蛋白的抑制作用适度增加了巨噬细胞向高密度脂蛋白的胆固醇外流。
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1132-8. doi: 10.1161/ATVBAHA.106.138347. Epub 2007 Feb 22.
10
Reverse cholesterol transport and cholesterol efflux in atherosclerosis.动脉粥样硬化中的胆固醇逆向转运与胆固醇流出
QJM. 2005 Dec;98(12):845-56. doi: 10.1093/qjmed/hci136. Epub 2005 Oct 28.

引用本文的文献

1
Analysis of the association between long-term exposure to low-dose ionizing radiation and dyslipidemia and its components in medical radiologists: The mediating role of inflammatory markers.医学放射科医生长期低剂量电离辐射暴露与血脂异常及其组分之间的关联分析:炎症标志物的中介作用
Int J Cardiol Cardiovasc Risk Prev. 2025 Apr 12;25:200406. doi: 10.1016/j.ijcrp.2025.200406. eCollection 2025 Jun.
2
Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease.2型糖尿病合并脂肪性肝病患者血脂异常发病机制及治疗中的性别差异
Front Med (Lausanne). 2024 Sep 23;11:1458025. doi: 10.3389/fmed.2024.1458025. eCollection 2024.
3
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review.
女性脂蛋白代谢、血脂异常及降脂治疗:综述
Pharmaceuticals (Basel). 2024 Jul 9;17(7):913. doi: 10.3390/ph17070913.
4
Beyond hot flashes: Exploring the role of estrogen therapy in postmenopausal women for myocardial infarction prevention and recovery.超越热潮:探索雌激素治疗在绝经后妇女中的作用,以预防和恢复心肌梗死。
Biomol Biomed. 2024 Jan 3;24(1):4-13. doi: 10.17305/bb.2023.9535.
5
Effect of Clinical and Laboratory Parameters on HDL Particle Composition.临床和实验室参数对高密度脂蛋白颗粒组成的影响。
Int J Mol Sci. 2023 Jan 19;24(3):1995. doi: 10.3390/ijms24031995.
6
Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis.不同病理生理条件下卵磷脂胆固醇酰基转移酶改变的影响:一项45年的文献计量学分析。
Front Pharmacol. 2022 Dec 14;13:1062249. doi: 10.3389/fphar.2022.1062249. eCollection 2022.
7
Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia.异常胆固醇处理的系统后果:炎症和血脂异常的相互依存途径。
Front Immunol. 2022 Aug 26;13:972140. doi: 10.3389/fimmu.2022.972140. eCollection 2022.
8
Measures of high-density lipoprotein function in men and women with severe aortic stenosis.男性和女性严重主动脉瓣狭窄患者高密度脂蛋白功能的测量。
Lipids Health Dis. 2022 May 28;21(1):48. doi: 10.1186/s12944-022-01653-7.
9
Challenges in Optimizing Lipid Management in Women.女性人群调脂管理面临的挑战
Cardiovasc Drugs Ther. 2022 Dec;36(6):1197-1220. doi: 10.1007/s10557-021-07273-0. Epub 2021 Oct 18.
10
Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study.绝经过渡期内内源性激素与高密度脂蛋白新指标的关联:SWAN-HDL 研究。
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e303-e314. doi: 10.1210/clinem/dgab595.